## NVDA: NVIDIA Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -1.1% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($163.65)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Munro Partners Acquires New Stake in NVIDIA Corporation $NVDA**
- Source: MarketBeat | 20251216T114033 | Somewhat-Bullish | Relevance: 100%
- Munro Partners has acquired a significant new stake in NVIDIA Corporation, purchasing over 2 million shares valued at approximately $318 million, making it their largest holding. This comes as other institutional investors have also adjusted their positions in NVIDIA, and several Wall Street analysts have reiterated "buy" ratings with price targets around $240-$272. Additionally, recent insider selling by NVIDIA's CEO and a director totaling over $75 million has been disclosed.

**2. Nvidia acquires Slurm developer SchedMD to enhance its software capabilities**
- Source: SiliconANGLE | 20251216T010811 | Bullish | Relevance: 100%
- Nvidia Corp. has acquired SchedMD LLC, the company responsible for maintaining Slurm, a critical open-source platform for managing server clusters in the machine learning ecosystem. This acquisition aims to enhance Nvidia's software capabilities, particularly in optimizing AI training workloads across its accelerated computing platform. Slurm's scalability and specialized features make it well-suited for managing large GPU clusters and supercomputers, complementing Nvidia's hardware offerings.

**3. Nvidia bulks up open source offerings with an acquisition and new open AI models**
- Source: TechCrunch | 20251215T220831 | Bullish | Relevance: 100%
- Nvidia is expanding its open-source AI efforts through the acquisition of SchedMD, developers of the Slurm workload management system, and the release of its new Nemotron 3 family of open AI models. The acquisition aims to enhance Nvidia's position in high-performance computing and AI infrastructure, while the Nemotron 3 models are designed for efficient AI agent development. These moves reinforce Nvidia's commitment to open innovation and physical AI, supporting robotics and autonomous vehicle development.

**4. AlphaTON Capital Secures First NVIDIA B300 Chips with Supermicro HGX Systems**
- Source: GlobeNewswire | 20251215T152800 | Bullish | Relevance: 100%
- AlphaTON Capital announced it has secured its first NVIDIA B300 GPUs with Supermicro HGX Systems through its partner Atlantic AI. These chips will power the Cocoon AI Network, focusing on privacy-first AI infrastructure for everyday users. This deployment represents a significant step in democratizing advanced AI capabilities, shifting power dynamics from centralized control to user sovereignty.

**5. Nvidia Becomes a Major Model Maker With Nemotron 3**
- Source: WIRED | 20251215T140837 | Bullish | Relevance: 100%
- Nvidia, traditionally a chipmaker, has released Nemotron 3, a series of open-source AI models, data, and tools, marking its entry into serious model making. This move is strategic, as other AI companies are developing their own chips, potentially reducing their reliance on Nvidia's technology. By embracing open innovation and transparency, Nvidia aims to provide developers with the resources needed to build scalable AI agents, especially important given the rising popularity of open models from Chinese firms.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 19, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | Morgan Stanley | $250 | $235 | +6% |
| 2025-11-20 | Citigroup | $270 | $220 | +23% |
| 2025-11-20 | Barclays | $275 | $240 | +15% |
| 2025-11-20 | JP Morgan | $250 | $215 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | Morgan Stanley | main | Overweight |
| 2025-11-20 | Citigroup | main | Buy |
| 2025-11-20 | Barclays | main | Overweight |
| 2025-11-20 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 57 ($303.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (-0.4%)
- Blackrock Inc.: 7.9% (+1.0%)
- FMR, LLC: 4.0% (-1.5%)
- State Street Corpora: 4.0% (+0.2%)
- JPMORGAN CHASE & CO: 4.0% (+111.3%)

### Key Risks

1. High beta (2.28) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_10 falling (-2.4% 5d) with bearish MACD, trend may be turning.
3. Heavy insider selling: $304M sold (57 transactions in 90 days).
4. Near-term weakness: 5.5% below SMA50 despite long-term uptrend.

### Catalysts

- Analyst target momentum: 19 raises (avg +13%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.67 indicates undervaluation relative to growth. Forward P/E 23.7x attractive for 59% earnings growth. Quality metrics strong (ROE 107%, ROA 54%, margin 53%). Balance sheet: strong liquidity (4.5x), low leverage (D/E 0.36), $22.1B free cash flow. Revenue growth strong at 48% YoY. Analyst sentiment positive (19 raises, avg +13%). Insider selling cluster ($303.8M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4292.1B |
| Beta | 2.28 |
| 52W Range | $86.62 - $212.19 |
| Short Interest | 1.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.67 |
| Forward P/E | 23.7 |
| Current P/E | 37.6 |
| YoY Growth | 59.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.3% to -1.1% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.1pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.13x) but short-term weakness (below SMA20). RSI neutral at 42. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.09% (CS: 18) | Neutral |
| RSI_14 | 41.6 | Neutral |
| MACD Histogram | -0.35 | Bearish |
| vs SMA20 | 0.973x | Below |
| vs SMA50 | 0.945x | Below |
| vs SMA200 | 1.128x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $176.29
- **Stop Loss:** $163.65 (7.2% risk)
- **Target:** $188.93 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 79
- **Position Value:** $13,926.91
- **Portfolio %:** 13.93%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-25 (Est: $1.52)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.25 | $1.30 | +3.6% |
| 2025Q3 | $1.01 | $1.05 | +4.1% |
| 2025Q2 | $0.75 | $0.81 | +8.0% |
| 2025Q1 | $0.85 | $0.89 | +5.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*